These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34519815)

  • 1. Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519815
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care.
    Ko JH; Joo EJ; Kim SH; Kim YJ; Huh K; Cho SY; Kang CI; Chung DR; Kang ES; Peck KR
    J Microbiol Immunol Infect; 2021 Feb; 54(1):97-100. PubMed ID: 32684340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic.
    Nguyen T; Wolff A
    Bioanalysis; 2021 Aug; 13(15):1165-1167. PubMed ID: 34286599
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing in the workplace: finding a path through a pandemic.
    Briscoe J
    Bioanalysis; 2021 Dec; 13(24):1785-1788. PubMed ID: 34789010
    [No Abstract]   [Full Text] [Related]  

  • 5. Pooled sputum to optimise the efficiency and utility of rapid, point-of-care molecular SARS-CoV-2 testing.
    Burdett A; Toumazou C; Sahoo R; Mujan A; Hon TK; Bedzo-Nutakor J; Casali N; Karvela M; Sohbati M; Cooke GS; Davies GW; Moore LSP
    BMC Infect Dis; 2021 Jul; 21(1):665. PubMed ID: 34238234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 2.
    Briscoe CJ; Barfield M
    Bioanalysis; 2021 Dec; 13(24):1779-1780. PubMed ID: 34806409
    [No Abstract]   [Full Text] [Related]  

  • 7. Interpreting SARS-CoV-2 Test Results.
    Coffey KC; Diekema DJ; Morgan DJ
    JAMA; 2021 Oct; 326(15):1528-1529. PubMed ID: 34533581
    [No Abstract]   [Full Text] [Related]  

  • 8. Are T cell repertoires useful as diagnostics for SARS- CoV- 2 infection?
    Harris T; Sauer K
    Expert Rev Mol Diagn; 2021 Feb; 21(2):137-139. PubMed ID: 33595410
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.
    Krause E; Puyskens A; Bourquain D; Brinkmann A; Biere B; Schaade L; Michel J; Nitsche A
    Mol Cell Probes; 2021 Aug; 58():101742. PubMed ID: 33971264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.
    Wandtke T; Wędrowska E; Szczur M; Przybylski G; Libura M; Kopiński P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Need for More and Better Testing for COVID-19.
    Manabe YC; Sharfstein JS; Armstrong K
    JAMA; 2020 Dec; 324(21):2153-2154. PubMed ID: 33185688
    [No Abstract]   [Full Text] [Related]  

  • 12. Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis.
    Yoon SH; Yang S; Cho H; Eun S; Koo CM; Kim MK
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):503-517. PubMed ID: 33506942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Mboumba Bouassa RS; Veyer D; Péré H; Bélec L
    Int J Infect Dis; 2021 May; 106():8-12. PubMed ID: 33746093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP.
    Bokelmann L; Nickel O; Maricic T; Pääbo S; Meyer M; Borte S; Riesenberg S
    Nat Commun; 2021 Mar; 12(1):1467. PubMed ID: 33674580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Feb; 288():114024. PubMed ID: 33227341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-testing for SARS-CoV-2: importance of lay communication.
    Coste AT; Egli A; Greub G
    Swiss Med Wkly; 2021 May; 151():w20526. PubMed ID: 34101820
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid COVID-19 testing: Speed, quality and cost. Can you have all three?
    Beach LA; Fung AWS; Knauer MJ; Shaw JLV; Taher J
    Clin Biochem; 2021 Sep; 95():13-14. PubMed ID: 34048775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Testing Tests Our Mettle.
    Hefferon KL; St Juliana JR; Miller HI
    Mo Med; 2020; 117(5):417-420. PubMed ID: 33311741
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited Diagnostic Utility of SARS-CoV-2 Serologic Testing in Symptomatic PCR Negative Patients.
    Tawiah KD; Hock KG; Farnsworth CW
    J Appl Lab Med; 2021 Jul; 6(4):1083-1085. PubMed ID: 33749743
    [No Abstract]   [Full Text] [Related]  

  • 20. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
    Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
    J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.